MASI
Masimo Corporation
NASDAQ: MASI · HEALTHCARE · MEDICAL DEVICES
$178.46
-0.03% today
Updated 2026-04-29
Market cap
$9.34B
P/E ratio
46.47
P/S ratio
6.12x
EPS (TTM)
$3.84
Dividend yield
—
52W range
$126 – $179
Volume
1.6M
WallStSmart proprietary scores
53
out of 100
Grade: C
Hold
Investment rating
6.0
Growth
B7.0
Quality
B+6.5
Profitability
B4.0
Valuation
C5/9
Piotroski F-Score
Moderate
2.4
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$180.00
+0.86%
12-Month target
—
—
Intrinsic (DCF)
$157.54
Margin of safety
+14.28%
0 Strong Buy0 Buy8 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 23.40% — strong efficiency
+ Free cash flow $53.40M — positive
+ Revenue growth 12.00% QoQ
+ 14.28% below intrinsic value
Risks
- Thin margins at -9.92%
- P/E 46.47x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.04B | $2.05B | $2.09B | $1.53B | $1.53B |
| Net income | $143.50M | $81.50M | $-304.90M | $-151.50M | $68.30M |
| EPS | — | — | — | — | $3.84 |
| Free cash flow | $-26.90M | $6.40M | $145.30M | $198.40M | $53.40M |
| Profit margin | 7.05% | 3.98% | -14.56% | -9.92% | -9.92% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-12 | POLITAN, CAPITAL MANAGEMENT LP | Buy | 130,869 | — |
| 2026-03-11 | YOUNG, MICAH W | Sale | 873 | — |
| 2026-03-11 | YOUNG, MICAH W | Buy | 873 | — |
Peer comparison
Smart narrative
Masimo Corporation trades at $178.46. representing a P/E of 46.47x trailing earnings. Our Smart Value Score of 53/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 2.44, it sits in the grey zone. TTM revenue stands at $1.53B. with profit margins at -9.92%. Our DCF model estimates intrinsic value at $157.54.
Frequently asked questions
What is Masimo Corporation's stock price?
Masimo Corporation (MASI) trades at $178.46.
Is Masimo Corporation overvalued?
Smart Value Score 53/100 (Grade C, Hold). DCF value $157.54.
What is the price target of Masimo Corporation (MASI)?
The analyst target price is $180.00, representing +0.9% upside from the current price of $178.46.
What is the intrinsic value of Masimo Corporation (MASI)?
Based on our DCF model, intrinsic value is $157.54, a +14.3% margin of safety versus $178.46.
What is Masimo Corporation's revenue?
TTM revenue is $1.53B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
2.44 — grey zone.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio6.12x
ROE23.40%
Beta1.20
50D MA$177.09
200D MA$152.54
Shares out0.05B
Float0.05B
Short ratio—
Avg volume1.6M
Performance
1 week-0.75%
1 month+1.00%
3 months+35.38%
YTD+36.18%
1 year—
3 years—
5 years—